AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Qiagen N.V. Director's Dealing 2016

Nov 22, 2016

4528_dirs_2016-11-22_618c4111-f109-451d-8702-bdbbd18a7464.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: HTG MOLECULAR DIAGNOSTICS, INC (HTGM)
CIK: 0001169987
Period of Report: 2016-11-17

Reporting Person: QIAGEN NV (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	833333	Indirect